In the BioHarmony Drug Report Database

"Preview" Icon

Etidocaine

Duranest (etidocaine) is a small molecule pharmaceutical. Etidocaine was first approved as Duranest on 1982-01-01. It is used to treat postoperative pain in the USA. It is known to target sodium channel protein type 2 subunit alpha.

 

Trade Name

 

Duranest
 

Common Name

 

etidocaine
 

ChEMBL ID

 

CHEMBL492
 

Indication

 

postoperative pain
 

Drug Class

 

Local anesthetics

Image (chem structure or protein)

Etidocaine structure rendering